The FDA is urging the inclusion of men in breast cancer clinical trials
Share to linkedin
Men with breast cancer have significantly fewer treatment options than women with the disease, partly due to exclusion from many clinical trials. A new document from the FDA is urging companies to include them in trials. Photo credit: Getty royalty-free.Men with breast cancer make up less than one percent of all breast cancer cases, but they are more likely than women to be diagnosed at a later stage of disease and at an older age, which can make treating the cancer more challenging.
"Today we issued a draft guidance encouraging the inclusion of male patients in breast cancer clinical trials," said Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.
"I couldn’t find a breast cancer trial in Australia, and there were very few in the US that that guys I know with this disease could participate in," said
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Apparently Men Don't Know How To Not Harass Female Coworkers, So They're Just Avoiding ThemThis was not the point of MeToo.
Read more »
From Radiation-Proof Boxers To The Pill For Men, Male Health Is The Latest Craze In TechMen are increasingly taking interest in their fertility and sexual health, and startups are riding the wave.
Read more »
YouTube CEO Susan Wojcicki: Here's what to say when men are talking over you at a meetingYouTube CEO Susan Wojcicki has worked in the tech industry for more than 20 years, but she says she still feels she has to go the extra mile to get the respect and attention she deserves.
Read more »
AstraZeneca shares hit record after Farxiga study--AstraZeneca's phase 3 DAPA-HF clinical trial of Farxiga yielded positive results --The data supports an expanded label for Farxiga for both patients with and without diabetes --Financial analysts praised the trial results Shares of AstraZeneca PLC (AZN.LN) reached an all-time high Monday after a clinical study of its drug Farxiga, originally designed to treat diabetes, showed the medicine helped patients who had suffered from heart failure.
Read more »